KaydedilenlerDerginizi ekleyin

Dergiler / Abant Tıp Dergisi / 2013 / Cilt: 2 - Sayı: 3

Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı

Sensorineural type hearing loss with pegylated interferon alfa/ribavirin therapy

Nazan TUNA
Aziz ÖĞÜTLÜ
Oğuz KARABAY
Süleyman CESUR
Deniz GİN
Mehmet GÜVEN
Sayfa
248–249
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

TUNA, N., ÖĞÜTLÜ, A., KARABAY, O., CESUR, S., GİN, D., GÜVEN, M. (2022). Pegile İnterferon alfa/ribavirin tedaviyle gelişen sensorinöral tipte işitme kaybı. Abant Tıp Dergisi, Cilt: 2 - Sayı: 3, 248–249. https://ajindex.com/articles/427199

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Howaizi M. Pegylated interferon-induced eyelid and eye- brow trichomegaly during chronic hepatitis C. J Gastroenterol Hepatol 2005; 20: 1945–1946.
  2. Goksugur N, Karabay O. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a. Clin Exp Dermatol 2007; 32: 583–584.
  3. Karabay O, Goksugur N, Ogutlu A. Tongue hyperpigmentation during interferon therapy. Journal of Dermatology. 2011; 38: 290-291.
  4. Johnson K, Sargent LA, Galizio C, Ubogu EU. Interferon- alfa-2b/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient. Eur J Gastroenterol Hepatol 2008; 20: 1110-1114.
  5. Atuğ O, Akın H, Yılmaz Y, Sarı M, Tozun N. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C. J Gastrointestin Liver Dis 2009; 18: 256. Elloumi H, Houissa F, Hadj BN, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment. World J gastroenterol 2007; 28: 5411-5412.
  6. Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004; 99: 873–877.
  7. Wong VK, Cheong-Lee C, Ford JA, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination theraphy during hepatitis C treatment: Outcome after resumption of theraphy. World J Gastroenterol 2005; 11: 5392-5393.
  8. Piekarska A, Jozefowicz-Korczynska M, Wojcik K, Berkan E. Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin. Int J Audiol 2007; 46(7): 345-350.
  9. Hagr A, Jamjoom D, Sanai F.M, Al Hamoudi W, Abdo A.A, Al-Arfaj A. Effect of interferon treatment on hearing of patients with chronic Hepatitis C. Saudi J Gastroenterol 2011; 2: 114-118.
  10. Akyol MU, Sarac S, Akyol G, Atac A, Poyraz A, Belgin E, Turan E. Investigation of the ototoxic effects of interferon alpha2A on the mouse cochlea Otolaryngol Head Neck Surg 2001;124(1): 107-110.